IntriCon completes divestiture of RTI Electronics

NewsGuard 100/100 Score

IntriCon Corporation (NASDAQ:IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group. Financial terms of the deal were not disclosed.

“Completing the divestiture allows us to devote more resources and capital to our core body-worn device business. We have now positioned ourselves a 'pure play' in body-worn technology, which we believe will appeal to a wider range of investors.”

"We are very pleased to have found an excellent ownership group to take over RTI Electronics and retain our skilled and dedicated group of electronics employees," said Mark S. Gorder, president and chief executive officer at IntriCon. "Completing the divestiture allows us to devote more resources and capital to our core body-worn device business. We have now positioned ourselves a 'pure play' in body-worn technology, which we believe will appeal to a wider range of investors."

IntriCon had previously disclosed its plan to divest RTI Electronics, and results of operations for the business have been reported in discontinued operations since the fourth quarter of fiscal 2009. Sargent Advisors LLC of Minneapolis, Minn., advised IntriCon on the transaction.

"RTI Electronics is the established leader in manufacturing high-quality thermistor, film capacitor and magnetic passive electronic components," said Mark Schelbert, managing partner of Shackleton Equity Partners. "Through our commitment to maintaining quality and our focus on new product development, we intend to serve the loyal customer base of RTI Electronics, while expanding our reach globally."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy